Status:
COMPLETED
Biofeedback for Dyssynergic Constipation
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Constipation
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Constipation affects 4% of adults in the United States (U.S.). An estimated half of constipated patients are unable to relax pelvic floor muscles during defecation, a type of constipation called pelvi...
Detailed Description
This study is a long-term prospective, single-blind study comparing biofeedback for pelvic floor dyssynergia to a skeletal muscle relaxant drug (diazepam 5 mg two hours before attempted defecation) an...
Eligibility Criteria
Inclusion
- Males or females ages 16 or above who have symptoms of constipation due to pelvic floor dyssynergia
Exclusion
- Pregnancy (because of the possibility of randomization into the diazepam group)
- Prior history of biofeedback treatment for pelvic floor disorders
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT00127257
Start Date
September 1 1999
End Date
June 1 2006
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina Department of Medicine
Chapel Hill, North Carolina, United States, 27599